Christian Cattaruzza de Lugan

• Global business leader for USP’s Biologics and Microbiology units. Oversee strategic planning, innovation pipeline, go-to-market execution, scientific outreach and external collaborations for biologics (therapeutic proteins and antibodies, cell and gene therapies, vaccines..), and microbiology. • Manage sales team dedicated to biologics customers in the regions and drive growth of the USP biologics and Microbiology portfolio in the life sciences and biopharmaceutical industries in collaboration with R&D and scientific affairs. • Lead strategic partnership and M&A initiatives for USP Biologics and Microbiology, in alignment with USP’s value-chain vision. • Spearheaded the acquisition and seamless integration of a microbiology company, expanding USP’s portfolio and strategic relevance. #Life Sciences Leadership, #Executive Leadership, #Strategic Partnerships, #Life Sciences Business Strategy, #Acquisitions in Life Sciences, #Cell and Gene Therapies, #Monoclonal Antibodies, #Sales Life Sciences, #Marketing Life Sciences

• Directed USP’s global Biologics business strategy and commercial operations. Repositioned the unit for accelerated growth, scientific leadership, and commercial impact. • Implemented a framework for new standards pipeline prioritization resulting in increased efficiency. Tripled the pace of new product development and market launch (300% YoY growth in 2024). • Restructured sales channels and introduced new digital marketing strategies, enhancing lead generation and brand equity. • Led the organization towards investigating new adjacent market opportunities (e.g. Microbiology) • Drove USP’s market entry into Adeno Associated Virus (AAV)-based gene therapies, addressing the existing lack of analytical best practices and standardized methods for viral vectors characterization, testings and assessment of product and process related impurities.

Stratix labs is a Microbiology technology company based in St. Paul, Minnesota. Microbiological quality control is essential to ensure fundamental contamination control measures are in place during pharmaceutical production and preparation. Increased demand and expedited timelines require the industry to identify and implement new approaches to microbial quality control throughout the drug production process, particularly for sterile products. Stratix labs helps drug manufacturers, developers and compounding entities address industry gaps in microbial contamination control strategies, mitigating the risk of contaminated products reaching patients.

Pharmatech Associates is a CMC Consulting firm based in San Francisco, California. Pharmatech Associates extends support to biopharmaceutical drug developers and manufacturers as they navigate the complexities of regulatory, scientific, and business environments and help them bring safe quality medicines and treatments to patients who need them.

#Life Sciences Sales Strategy, #Biotech Sales Growth, #Go to Market Strategy in Life Sciences, #Life Sciences Business Development, #Emerging Markets in Life Sciences